• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中的趋化因子:调节代谢。

Chemokines in breast cancer: Regulating metabolism.

机构信息

Dept. Immunology, University of Toronto, 1 King's College Circle, Medical Sciences Bldg., Toronto, Ontario M5S 1A8, Canada; Toronto General Hospital Research Institute, University Health Network, 67 College Street, Toronto, Ontario M5G 2M1, Canada.

出版信息

Cytokine. 2018 Sep;109:57-64. doi: 10.1016/j.cyto.2018.02.010.

DOI:10.1016/j.cyto.2018.02.010
PMID:29903574
Abstract

Accumulating evidence indicates that chemokine-chemokine receptor interactions invoke biological responses beyond their originally described function of orchestrating leukocyte trafficking. In this review we will extend the findings that chemokines participate actively in the neoplastic process, and consider the contribution of CCL5 activation of CCR5 on breast cancer cells to upregulation of anabolic metabolic events that would support the energy demands of cell replication and proliferation.

摘要

越来越多的证据表明,趋化因子-趋化因子受体相互作用引发的生物学反应超出了它们最初描述的协调白细胞迁移的功能。在这篇综述中,我们将扩展趋化因子积极参与肿瘤发生过程的发现,并考虑 CCL5 激活乳腺癌细胞上的 CCR5 对上调合成代谢事件的贡献,这些事件将支持细胞复制和增殖的能量需求。

相似文献

1
Chemokines in breast cancer: Regulating metabolism.乳腺癌中的趋化因子:调节代谢。
Cytokine. 2018 Sep;109:57-64. doi: 10.1016/j.cyto.2018.02.010.
2
CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis.CCL5与CCR5的相互作用在肿瘤发生过程中调节代谢事件以促进肿瘤发生。
BMC Cancer. 2017 Dec 8;17(1):834. doi: 10.1186/s12885-017-3817-0.
3
CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells.CCL5对CCR5的激活调节细胞代谢,以增强乳腺癌细胞的增殖。
Open Biol. 2016 Jun;6(6). doi: 10.1098/rsob.160122.
4
Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.癌细胞CCL5介导乳腺癌中不依赖骨髓的血管生成。
Oncotarget. 2016 Dec 20;7(51):85437-85449. doi: 10.18632/oncotarget.13387.
5
The potential to target CCL5/CCR5 in breast cancer.靶向乳腺癌中 CCL5/CCR5 的潜力。
Expert Opin Ther Targets. 2014 Nov;18(11):1265-75. doi: 10.1517/14728222.2014.949238. Epub 2014 Sep 26.
6
Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration.结直肠癌微环境中CXCL10和CCL5的活性分泌与颗粒酶B阳性CD8阳性T细胞浸润相关。
Oncotarget. 2015 Feb 20;6(5):2981-91. doi: 10.18632/oncotarget.3205.
7
Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.抑制 CCL5/CCR5 轴对胃癌进展的作用。
Int J Mol Sci. 2018 May 16;19(5):1477. doi: 10.3390/ijms19051477.
8
Critical roles of chemokine receptor CCR5 in regulating glioblastoma proliferation and invasion.趋化因子受体CCR5在调节胶质母细胞瘤增殖和侵袭中的关键作用。
Acta Biochim Biophys Sin (Shanghai). 2015 Nov;47(11):890-8. doi: 10.1093/abbs/gmv095. Epub 2015 Sep 20.
9
Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.肿瘤源趋化因子 CCL5 通过调节性 T 细胞增强 TGF-β 介导的结肠癌中 CD8(+) T 细胞的杀伤作用。
Cancer Res. 2012 Mar 1;72(5):1092-102. doi: 10.1158/0008-5472.CAN-11-2493. Epub 2012 Jan 26.
10
CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.CCL5/CCR5 轴诱导人骨肉瘤微环境中血管内皮生长因子介导的肿瘤血管生成。
Carcinogenesis. 2015 Jan;36(1):104-14. doi: 10.1093/carcin/bgu218. Epub 2014 Oct 20.

引用本文的文献

1
The Chemokines Initiating and Maintaining Immune Hot Phenotype Are Prognostic in ICB of HNSCC.启动和维持免疫热表型的趋化因子在头颈部鳞状细胞癌的免疫检查点阻断治疗中具有预后意义。
Front Genet. 2022 May 27;13:820065. doi: 10.3389/fgene.2022.820065. eCollection 2022.
2
An Immune Feature-Based, Three-Gene Scoring System for Prognostic Prediction of Head-and-Neck Squamous Cell Carcinoma.一种基于免疫特征的三基因评分系统用于头颈部鳞状细胞癌的预后预测
Front Oncol. 2022 Jan 11;11:739182. doi: 10.3389/fonc.2021.739182. eCollection 2021.
3
An Update on Glioblastoma Biology, Genetics, and Current Therapies: Novel Inhibitors of the G Protein-Coupled Receptor CCR5.
胶质母细胞瘤生物学、遗传学和当前治疗方法的最新进展:G 蛋白偶联受体 CCR5 的新型抑制剂。
Int J Mol Sci. 2021 Apr 24;22(9):4464. doi: 10.3390/ijms22094464.
4
Intrahepatic Expression of C-C Motif ligand 5 in Patients with Chronic Hepatitis B.慢性乙型肝炎患者肝内 C-C 基序趋化因子配体 5 的表达
Turk J Gastroenterol. 2021 Jan;32(1):76-81. doi: 10.5152/tjg.2020.19566.
5
Bone Marrow Adipocytes, Adipocytokines, and Breast Cancer Cells: Novel Implications in Bone Metastasis of Breast Cancer.骨髓脂肪细胞、脂肪细胞因子与乳腺癌细胞:对乳腺癌骨转移的新启示
Front Oncol. 2020 Oct 2;10:561595. doi: 10.3389/fonc.2020.561595. eCollection 2020.
6
The CCL5/CCR5 Axis in Cancer Progression.癌症进展中的CCL5/CCR5轴
Cancers (Basel). 2020 Jul 2;12(7):1765. doi: 10.3390/cancers12071765.
7
Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.超越细胞迁移:趋化因子及其受体在恶性肿瘤中的作用不断扩大。
Front Immunol. 2020 Jun 4;11:952. doi: 10.3389/fimmu.2020.00952. eCollection 2020.
8
Reactive Glia Inflammatory Signaling Pathways and Epilepsy.活性神经胶质炎症信号通路与癫痫
Int J Mol Sci. 2020 Jun 8;21(11):4096. doi: 10.3390/ijms21114096.
9
The G protein coupled receptor CCR5 in cancer.G 蛋白偶联受体 CCR5 在癌症中的作用。
Adv Cancer Res. 2020;145:29-47. doi: 10.1016/bs.acr.2019.11.001. Epub 2020 Jan 10.
10
Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology.针对癌症的 CCR5 靶点及在免疫肿瘤学中的作用的最新进展
Cancer Res. 2019 Oct 1;79(19):4801-4807. doi: 10.1158/0008-5472.CAN-19-1167. Epub 2019 Jul 10.